Cartesian Therapeutics, Inc. - SIC # 2834 - PHARMACEUTICAL PREPARATIONS

Ticker Exchange SIC # Website Latest Ticker
RNAC Nasdaq 2834 www.cartesiantherapeutics.com

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Cartesian Therapeutics, Inc.

Cartesian Therapeutics Announces New Employment Inducement Grants - Sep 8th, 2026 5:00 am
Cartesian Therapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - Aug 6th, 2026 5:00 am
Kyverna Therapeutics Sinks 13%: Here’s Why - Jul 10th, 2026 1:59 pm
New Strong Sell Stocks for July 1st - Jul 1st, 2026 1:33 am
Cartesian Therapeutics Announces New Employment Inducement Grant - Jun 12th, 2026 2:05 pm
AstraZeneca’s ‘extensive’ obesity drug push; $125M for ultrasound-aided genetic medicine - Jun 10th, 2026 3:12 am
Cartesian Therapeutics Announces Strategic Licensing Agreement with WestGene Biopharma to Accelerate the Development of In Vivo CAR-T Platform in Autoimmune Diseases - Jun 9th, 2026 5:00 am
Cartesian Therapeutics Secures up to $150 Million of Non-Dilutive Financing from K2 HealthVentures and Expects Topline Data from the Phase 3 AURORA Trial in First Quarter 2027 - May 26th, 2026 5:00 am
Emerging Hope in Multiple Myeloma Market: 7 Late-Stage Therapies Nearing the Finish Line | DelveInsight - May 25th, 2026 11:00 am
Myasthenia Gravis Market Set to Surpass USD 16 Billion by 2036, Fueled by Rising Diagnosed Prevalence and Wave of Targeted Biologic Approvals | DelveInsight - May 18th, 2026 11:00 am
We're Keeping An Eye On Cartesian Therapeutics' (NASDAQ:RNAC) Cash Burn Rate - May 17th, 2026 8:04 am
Cartesian Therapeutics to Participate in the H.C. Wainwright 4th Annual BioConnect Investor Conference at NASDAQ - May 12th, 2026 5:00 am
Cartesian Therapeutics, Inc. (RNAC) Reports Q1 Loss, Lags Revenue Estimates - Apr 30th, 2026 6:30 am
Cartesian Therapeutics Reports First Quarter 2026 Financial Results and Provides Business Update - Apr 30th, 2026 5:00 am